Song Yutong, Ding Yewei, Su Junyi, Li Jian, Ji Yuanhui
Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, School of Chemistry and Chemical Engineering, Southeast University, Nanjing, 211198, P.R. China.
Jinling Pharmaceutical Co., Ltd., Nanjing, 210009, P.R. China.
Angew Chem Int Ed Engl. 2025 May;64(21):e202502410. doi: 10.1002/anie.202502410. Epub 2025 Mar 24.
Co-crystal engineering is of interest for many applications in pharmaceutical, chemical, and materials fields, but rational design of co-crystals is still challenging. Although artificial intelligence has revolutionized decision-making processes in material design, limitations in generalization and mechanistic understanding remain. Herein, we sought to improve prediction of co-crystals by combining mechanistic thermodynamic modeling with machine learning. We constructed a brand-new co-crystal database, integrating drug, coformer, and reaction solvent information. By incorporating various thermodynamic models, the predictive performance was significantly enhanced. Benefiting from the complementarity of thermodynamic mechanisms and structural descriptors, the model coupling three thermodynamic models achieved optimal predictive performance in coformer and solvent screening. The model was rigorously validated against benchmark models using challenging independent test sets, showcasing superior performance in both coformer and solvent predicting with accuracy over 90%. Further, we employed SHAP analysis for model interpretation, suggesting that thermodynamic mechanisms are prominent in the model's decision-making. Proof-of-concept studies on ketoconazole validated the model's efficacy in identifying coformers/solvents, demonstrating its potential in practical application. Overall, our work enhanced the understanding of co-crystallization and highlighted the strategy that integrates mechanistic insights with data-driven models to accelerate the rational design and synthesis of co-crystals, as well as various other functional materials.
共晶工程在制药、化学和材料领域的许多应用中备受关注,但共晶的合理设计仍然具有挑战性。尽管人工智能已经彻底改变了材料设计中的决策过程,但在泛化和机理理解方面仍存在局限性。在此,我们试图通过将机理热力学建模与机器学习相结合来改进共晶的预测。我们构建了一个全新的共晶数据库,整合了药物、共形成物和反应溶剂信息。通过纳入各种热力学模型,预测性能得到了显著提高。受益于热力学机制和结构描述符的互补性,耦合三种热力学模型的模型在共形成物和溶剂筛选中实现了最佳预测性能。使用具有挑战性的独立测试集对该模型与基准模型进行了严格验证,结果表明该模型在共形成物和溶剂预测方面均表现出色,准确率超过90%。此外,我们采用SHAP分析对模型进行解释,结果表明热力学机制在模型决策中占主导地位。酮康唑的概念验证研究证实了该模型在识别共形成物/溶剂方面的有效性,证明了其在实际应用中的潜力。总体而言,我们的工作增进了对共结晶的理解,并突出了将机理见解与数据驱动模型相结合的策略,以加速共晶以及各种其他功能材料的合理设计与合成。